z-logo
open-access-imgOpen Access
HER2‑amplified metastatic lung adenocarcinoma responds to fourth‑line pyrotinib therapy: A case report
Author(s) -
Kan Gong,
Yi Yang,
Huan Huang,
Xunjie Kuang,
Xueqin Yang
Publication year - 2021
Publication title -
molecular and clinical oncology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.442
H-Index - 7
eISSN - 2049-9469
pISSN - 2049-9450
DOI - 10.3892/mco.2021.2375
Subject(s) - medicine , lapatinib , trastuzumab , oncology , nivolumab , adenocarcinoma , lung cancer , regimen , lung , cancer , chemotherapy , breast cancer , immunotherapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom